Business Description
Virpax Pharmaceuticals Inc
NAICS : 541714
SIC : 2833
ISIN : US9282511073
Share Class Description:
VRPX: Ordinary SharesDescription
Virpax Pharmaceuticals Inc is a preclinical stage biopharmaceutical company. The company is focused on developing pharmaceutical product candidates for pain management. Its product portfolio includes Topical metered-dose spray; Liposomal in Hydrogel encapsulation; and Enkephalin Intranasal spray.
Financial Strength
8/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | No Debt | |||||
| Equity-to-Asset | 0.2 | |||||
| Interest Coverage | No Debt | |||||
| Piotroski F-Score | 3/9 | |||||
| WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year EBITDA Growth Rate | -15.9 | |||||
| 3-Year EPS without NRI Growth Rate | -13.4 | |||||
| 3-Year FCF Growth Rate | -39.9 |
Momentum Rank
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 29.5 | |||||
| 9-Day RSI | 35.27 | |||||
| 14-Day RSI | 39.98 | |||||
| 6-1 Month Momentum % | -46.37 | |||||
| 12-1 Month Momentum % | -44.03 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 1.25 | |||||
| Quick Ratio | 1.25 | |||||
| Cash Ratio | 1.19 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | -37.5 |
Profitability Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| ROE % | -144.6 | |||||
| ROA % | -98.91 | |||||
| ROIC % | -525.91 | |||||
| ROCE % | -173.16 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PB Ratio | 1.95 | |||||
| Price-to-Tangible-Book | 1.95 | |||||
| EV-to-EBIT | 0.3 | |||||
| EV-to-EBITDA | 0.3 | |||||
| EV-to-FCF | 0.54 | |||||
| Price-to-Net-Current-Asset-Value | 1.95 | |||||
| Price-to-Net-Cash | 2.6 | |||||
| Earnings Yield (Greenblatt) % | 333.33 | |||||
| FCF Yield % | -261.28 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with NAS:VRPX
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Peter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Virpax Pharmaceuticals Inc Executives
DetailsGF Value
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil $) | |||
| EPS (TTM) ($) | -12.97 | ||
| Beta | 1.45 | ||
| Volatility % | 81.9 | ||
| 14-Day RSI | 39.98 | ||
| 14-Day ATR ($) | 0.397564 | ||
| 20-Day SMA ($) | 3.75808 | ||
| 12-1 Month Momentum % | -44.03 | ||
| 52-Week Range ($) | 2.402 - 11.774 | ||
| Shares Outstanding (Mil) | 1.17 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 3 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Virpax Pharmaceuticals Inc Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Virpax Pharmaceuticals Inc Stock Events
| Event | Date | Price($) | ||
|---|---|---|---|---|
| No Event Data | ||||
Virpax Pharmaceuticals Inc Frequently Asked Questions
What is Virpax Pharmaceuticals Inc(VRPX)'s stock price today?
The current price of VRPX is $3.22. The 52 week high of VRPX is $11.77 and 52 week low is $2.40.
When is next earnings date of Virpax Pharmaceuticals Inc(VRPX)?
The next earnings date of Virpax Pharmaceuticals Inc(VRPX) is 2024-05-10 Est..
Does Virpax Pharmaceuticals Inc(VRPX) pay dividends? If so, how much?
Virpax Pharmaceuticals Inc(VRPX) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers